WASHINGTON, Dec. 8 -- The U.S. Department of Health and Human Services Food and Drug Administration issued a notice of availability in the Federal Register on Nov. 29, 2024, entitled "Use of Circulating Tumor Deoxyribonucleic Acid for Curative-Intent Solid Tumor Drug Development; Guidance for Industry". Here are excerpts: * * * SUMMARY: The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance for industry entitled "Use of Circulating Tumor DNA for   more